Curtis Lockshin
Director, Protalix Biotherapeutics Inc.
Companies
- Phio Pharmaceuticals Corp.Board member Apr 22, 2013 to now1
- Xenetic Biosciences (United States)Chief Scientific Officer Jan 6, 2017 to Dec 13, 20232
- Niagen Bioscience, Inc.Board member Mar 31, 2011 to Dec 26, 20123
- Sorrento TherapeuticsBoard member Jul 8, 2008 to Jul 20, 20124
- BioCardia, Inc.Board member Nov 13, 2007 to Aug 27, 20085
- Protalix Biotherapeutics IncBoard member Mar 29, 2007 to Mar 29, 20076
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Phio Pharmaceuticals Corp. PHIO35,155 shares7$32.6K at $0.93Feb 5, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 5, 2026Granted 16,600 shares of Phio Pharmaceuticals Corp.7
- Sep 11, 2025Granted 16,200 shares of Phio Pharmaceuticals Corp.8
- Sep 11, 2024Granted 2,000 shares of Phio Pharmaceuticals Corp.9
- Feb 17, 2023Granted 1,500 shares of Phio Pharmaceuticals Corp.10
- Feb 15, 2022Granted 10,000 shares of Phio Pharmaceuticals Corp.11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARSorrento Therapeutics, Board member
- 5SEC EDGARBioCardia, Inc., Board member
- 6
- 7
- 8SEC EDGARForm 4 filed Sep 15, 2025
- 9SEC EDGARForm 4 filed Sep 12, 2024
- 10SEC EDGARForm 4 filed Feb 22, 2023
- 11SEC EDGARForm 4 filed Feb 16, 2022